Cita APA

Singleton, K. W., Johnston, S. K., Hawkins-Daarud, A., Rickertsen, C. R., De Leon, G., Kunkel, L., . . . Swanson, K. R. (2017). NIMG-93. DISCRIMINATION OF CLINICALLY IMPACTFUL TREATMENT RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB TREATMENT. Neuro Oncol.

Chicago Style Citation

Singleton, Kyle W., et al. "NIMG-93. DISCRIMINATION OF CLINICALLY IMPACTFUL TREATMENT RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB TREATMENT." Neuro Oncol 2017.

Cita MLA

Singleton, Kyle W., et al. "NIMG-93. DISCRIMINATION OF CLINICALLY IMPACTFUL TREATMENT RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB TREATMENT." Neuro Oncol 2017.